Health Indicator Report of Deaths due to Prostate Cancer
Prostate cancer is the most common cancer among men[http://www.cdc.gov/cancer/prostate/ ^1^] and, in New Jersey, is the third leading cause of death due to cancer among men.
NotesThis is Healthy New Jersey 2020 (HNJ2020) Objective CA-7. Data for White and Black do not include Hispanics. Hispanic ethnicity includes persons of any race. The number of deaths among Asian men is too small to calculate a reliable annual rates.
- Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health
- Population Estimates, State Data Center, New Jersey Department of Labor and Workforce Development
DefinitionDeaths with malignant neoplasm (cancer) of the prostate as the underlying cause of death ICD-10 code: C61
NumeratorNumber of deaths among males due to cancer of the prostate
DenominatorTotal number of males in the population
Healthy People Objective: Reduce the prostate cancer death rateU.S. Target: 21.8 deaths per 100,000 males (age-adjusted)
State Target: 21.2 deaths per 100,000 males (age-adjusted)
Other Objectives'''Healthy New Jersey 2020 Objective CA-7''': Reduce the age-adjusted mortality rate due to prostate cancer per 100,000 standard male population to 21.2 for the total population, 19.6 among Whites, 48.1 among Blacks, and 17.6 among Hispanics.
How Are We Doing?The death rate due to prostate cancer among all New Jersey males is trending downward and each Healthy New Jersey 2020 target has been met. The rate among Blacks has nearly halved since 2000 but remains more than double the rates among Whites and Hispanics.
How Do We Compare With the U.S.?The age-adjusted death rate due to prostate cancer among New Jersey males is statistically significantly below that of the nation as a whole.
Available ServicesThe New Jersey Cancer Education and Early Detection (NJCEED) Program provides comprehensive outreach, education and screening services for prostate cancer. [http://www.nj.gov/health/ces/public/resources/njceed.shtml]
Page Content Updated On 07/14/2017, Published on 08/03/2017